WebFeb 4, 2013 · SYGNIS Pharma - the "new" one: development and commercialisation of molecular diagnostics products. Heidelberg-based SYGNIS Pharma AG is to discontinue its therapeutic R&D projects targeting human nervous system diseases and will in future focus on the research and development of novel molecular biology technologies, including DNA … WebSygnis New Technologies is a hardware house. We create new industrial solutions and machines tailored to our client’s needs. Our original projects co-solve global problems of …
Open Source DIY Telescope Prime Features Raspberry Pi and 3D …
WebApr 11, 2024 · In Q1 2024, the Sygnis Group reported a net profit of PLN 3.4M, a 213% increase compared to 2024. The total revenue for the three quarters of 2024 reached PLN … WebJul 18, 2012 · The SYGNIS team and its Heidelberg biotech network offer us direct access to the scientific excellence of that region; we will use this huge potential to its full effect.” For further information please contact: SYGNIS Pharma AG. Peter Willinger. CFO. SYGNIS Pharma AG Tel: +49 6221 454 836. Email: [email protected] GENETRIX, S.L. bishez.com
10 Breakthrough Technologies 2024 MIT Technology Review
http://sygnis.tomaszwierzbowski.pl/bio/ WebMar 14, 2024 · Sygnis SA is a “deeptech company” that is involved in research and development in the field of hardware technology. Sygnis Group says it is currently working on numerous projects that address ... WebSygnis New Technologies. Zwirki I Wigury 101. 02-089 Warsaw. POLAND. Phone: +48 664 776 536. E-mail: [email protected]. www.sygnis.pl SYGNIS New Technologies specializes in high-tech 3D printing solutions in wide range of techniques. Our partner Sondasys is a first polish producer of production level SLS, SLA and SLM machines. bis heute cob